Shanghai Haixin Group Co., Ltd.

600851

CNE000000CF1

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
5.77 ^CNY	-0.69%		-1.87%	-16.01%

Apr. 26	Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 19	Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Shanghai Haixin Group Co., Ltd. Announces Cash Dividend Per A Share and B Share

July 23, 2020

Shanghai Haixin Group Co., Ltd. announced cash dividend of RMB 0.03 (taxes included) per A share, and a cash dividend of USD 0.004231 (taxes included) per B share. Record date for A shares: July 31, 2020. Record date for B shares: August 5, 2020. Ex-dividend date: August 3, 2020. Cash dividend payable date for A shares: August 3, 2020. Cash dividend payable date for B shares: August 13, 2020.

Latest news about Shanghai Haixin Group Co., Ltd.

Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 19	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Shanghai Haixin Group Co., Ltd.(XSSC:600851) added to S&P Global BMI Index	23-09-18	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-19	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-18	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-20	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-27	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-20	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-27	CI
Shanghai Haixin Group Co., Ltd.(SHSE:900917) dropped from FTSE All-World Index	20-09-21	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-27	CI
Shanghai Haixin Group Co., Ltd. Announces Cash Dividend Per A Share and B Share	20-07-23	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-04-28	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-27	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019	19-10-27	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019	19-08-26	CI
Shanghai Haixin Group Co., Ltd. Announces Divined on Share A and B, Payable on July 29, 2019 and August 9, 2019	19-07-21	CI
Shanghai Haixin Group Co., Ltd. Announces Financial Results for First Quarter of 2019	19-04-25	CI

Chart Shanghai Haixin Group Co., Ltd.

Duration

Period

More charts

Company Profile

Shanghai Haixin Group Co., Ltd. is a China based company principally engaged in the production and sales of textile products and pharmaceuticals. The Company operates its business through two segments. The Textile segment is mainly engaged in the production and sales of plush fabric and clothing. The Pharmaceutical segment is mainly engaged in the manufacture and sales of pharmaceutical products. In addition, The Company is also engaged in financial investment business and industrial plant rental management business. The Company operates its business in the domestic market and overseas markets.

Sector

Pharmaceuticals

Calendar

2024-08-28 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SHANGHAI HAIXIN GROUP CO., LTD.	-16.01%	719M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+22.35%	44.12B
OTSUKA HOLDINGS CO., LTD.	+22.22%	22.61B
SANDOZ GROUP AG	+17.81%	15.11B
CIPLA LIMITED	+15.73%	13.61B
ZYDUS LIFESCIENCES LIMITED	+57.91%	13.34B
ONO PHARMACEUTICAL CO., LTD.	-8.98%	6.94B
THE MEDICINES COMPANY	-0.05%	6.79B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.03%	5.75B
STADA ARZNEIMITTEL	-8.87%	5.73B

Generic Pharmaceuticals